NL-OMON51749
Recruiting
Not Applicable
Prospective, single-centre, feasibility study to evaluate the use of 18F-PSMA PET/CT in patients with biochemically active medullary thyroid cancer. - MIMETIC
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Medullary thyroid cancer
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 15
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following inclusion criteria:
- •\- At least 18 years of age
- •\- Histological or cytological proven MTC
- •\- Biochemical evidence of disease activity (elevated/increasing calcitonin
- •and/or CEA)
- •\- Clinical indication for an 18F\-FDG PET/CT
- •\- Able to follow instructions to participate in the study
- •\- Able to give informed consent
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study: \- Patients with prostate cancer or renal cell
- •carcinoma \- Pregnant patients \- Recent neck surgery (\<3 months ago)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Detecting early pre-symptomatic psoriatic arthritis in patients with skin moderate or severe psoriasis - how effective is ustekinumab (Stelara) in limiting joint disease progression and future disability?Psoriatic disease (psoriasis and psoriatic arthritis).MedDRA version: 14.1 Level: LLT Classification code 10066579 Term: Progression of psoriatic arthritis System Organ Class: 100000004859MedDRA version: 14.1 Level: LLT Classification code 10071117 Term: Plaque psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: LLT Classification code 10037160 Term: Psoriatic arthritis System Organ Class: 100000004859MedDRA version: 14.1 Level: LLT Classification code 10050576 Term: Psoriasis vulgaris System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: PT Classification code 10037153 Term: Psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: LLT Classification code 10037157 Term: Psoriasis of scalp System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: LLT Classification code 10063407 Term: Psoriasis genital System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: PT Classification code 10028703 Term: Nail psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2012-002640-25-GBniversity of Leeds/Leeds Teaching Hospitals NHS Trust30
Completed
Not Applicable
Oral glucose tolerance test in first trimester of pregnancyGestational diabetesNutritional, Metabolic, EndocrineISRCTN18906333Southend Hospital NHS Foundation Trust50
Completed
Phase 1
A multi-centered phase I study of feasibility in endoscopic hand suturing (EHS) of mucosal defects after gastric endoscopic submucosal dissectioearly gastric cancersJPRN-UMIN000033988ippon Medical School40
Recruiting
Not Applicable
An explorative, single-center, feasibility study to collect data for the continuous development of the TENA Bladder Sensor Algorithm in adults during urodynamics.Involuntary leakage of urineUrgency10046590NL-OMON51822Essity Hygiene and Health AB66
Completed
Not Applicable
A prospective, single arm feasibility study to evaluate the safety and performance of the SMT Embolic Deflection Device in patients undergoing Transcatheter Aortic Valve Replacement (TAVR)seizureStroke10046973NL-OMON37697SMT Medical Technologies10